SQZ Biotech to Present at H.C. Wainwright Global Life Sciences Conference
03 3월 2021 - 8:45PM
Business Wire
SQZ Biotechnologies (NYSE:SQZ), a cell therapy company
developing novel treatments for multiple therapeutic areas, today
announced that Armon Sharei, PhD, chief executive officer of SQZ™,
will present a corporate overview at the upcoming virtual H.C.
Wainwright Global Life Sciences Conference. The presentation will
be available through the virtual conference portal on Tuesday,
March 9, 2021 at 7:00 am EST. The team is also taking individual
meetings at the event.
Registration for the webcast can be found here. Replays of the
webcast will be available on the Investors & Media section of
the SQZ website for 90 days following the event.
About SQZ Biotech
SQZ Biotechnologies is a clinical-stage biotechnology company
developing transformative cell therapies for patients with cancer,
infectious diseases, and other serious conditions. Using its
proprietary technology, SQZ Biotechnologies offers the unique
ability to deliver multiple materials into many patient cell types
to engineer what we believe can be an unprecedented range of
potential therapeutics for a variety of diseases. SQZ
Biotechnologies has the potential to create well-tolerated cell
therapies that can provide therapeutic benefit for patients and to
improve the patient experience over existing cell therapy
approaches. With accelerated production timelines under 24 hours
and the opportunity to eliminate preconditioning and lengthy
hospital stays, our goal is to use the SQZ approach to establish a
new paradigm for cell therapies. Our first therapeutic applications
aim to leverage the potential to generate target-specific immune
responses, both in activation for the treatment of solid tumors and
immune tolerance for the treatment of unwanted immune reactions and
autoimmune diseases. For more information please visit
www.sqzbiotech.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210303005177/en/
SQZ IR: Rebecca Cohen Corporate and Investor Relations
rebecca.cohen@sqzbiotech.com 617-758-8672 ext. 728 Media:
Kate Contreras kcontreras@w2ogroup.com 617-229-5960
SQZ Biotechnologies (NYSE:SQZ)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
SQZ Biotechnologies (NYSE:SQZ)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024